· Original article
Tesla annual meeting set for December 3 with board, pay votes
Tesla annual meeting on December 3, 2026, will put three board seats, an advisory executive pay vote and the auditor appointment before shareholders.
FINANCEVELIX / News
Equities & companies · Page 264
Equities & companies
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
My news topics
My news topics →Choose topics to see up to three latest articles per topic in your account.
Your topic choices are private to your account. No email or push notifications.
Please wait…
Read the original source and publication date in each article.
Results: 4,010 · Page 264 / 335
· Original article
Cleveland-Cliffs earnings beat estimates as revenue falls short
Cleveland-Cliffs earnings beat Q3 estimates, but revenue missed forecasts. Higher steel prices supported profit and management's outlook for 2027.
· Original article
Cleveland-Cliffs earnings rebound to $165 million Q3 profit
Cleveland-Cliffs earnings returned to profit in Q3 2026 as steel prices improved, while management forecast further adjusted EBITDA growth in Q4.
· Original article
Costco shares up 15.2% in 2026; fiscal profit also grows
Costco shares reached $989.11 in an October 19 snapshot, up 15.2% in 2026, following higher fiscal-year sales and earnings.
· Original article
Nasdaq futures rise 1.4% after technology stocks retreat
Nasdaq futures rose 1.4% on October 19 after a sharp weekly decline, as AI spending concerns lingered and Meta and Tesla earnings approached.
· Original article
Wall Street futures split as Nasdaq rises and Dow slips
Wall Street futures were mixed on October 19, 2026, as Nasdaq contracts rose and the Dow slipped. Oil fell, while later housing data showed weakness.
· Original article
Blue Moon Metals grants Elmet board rights in C$35m deal
Blue Moon Metals closed a C$35 million placement with Elmet, granting investor rights and appointing William Jacob Homiller to its board.
· Original article
Ivonescimab trial opens sites for advanced kidney cancer
Summit and Akeso opened sites for a Phase II ivonescimab trial in untreated advanced kidney cancer, testing three regimens against a standard treatment.
· Original article
Glass House production hits record as Q3 margins narrow
Glass House production reached 317,000 pounds in Q3 2026, but lower selling prices squeezed margins. Management reaffirmed its annual output forecast.
· Original article
Chord Energy CEO Michael Lou Takes Over as Danny Brown Exits
Chord Energy CEO Michael Lou took office on October 19, 2026, replacing Danny Brown. The filing details the board change and compensation arrangements.
· Original article
Nasdaq futures rise 1.3% ahead of possible Wall Street rebound
Nasdaq futures rose 1.3% before the October 19 open after a technology selloff, while U.S. crude eased but remained above $100 a barrel.
· Original article
Westerman acquisition gives Centrus control of key supplier
Centrus completed its $116 million Westerman acquisition, bringing centrifuge-component manufacturing in-house and adding non-nuclear industrial customers.
Charts and market data by TradingView. Availability and delays vary by exchange.